Skip to main content
WBF What is
brain fog?
Support WBF Take quiz

Test guide Blood test

EBV Early Antigen D IgG: What a Positive Result Means

EA-D IgG is one extra EBV antibody. It can show up during a recent infection, but about 1 in 5 healthy people may still have it years later. Read it with VCA IgM, VCA IgG, EBNA IgG, the first day of illness, immune health, and this lab's cutoff.

A positive result may be old About 1 in 5 healthy people may keep this antibody for years. Use this lab's cutoff A number from one test method cannot be compared with a number from another. Read the whole panel Use VCA IgM, VCA IgG, EBNA IgG, the illness date, and immune health with this result.
01

What EA-D tests and what it misses

Read EA-D with the full antibody panel, illness dates, immune health, and any transplant plan. Together, these details show whether the result adds useful information.

What it finds

It finds an antibody to one part of EBV.

The test finds an immune response in blood. It does not count the virus or show where it is in the body.

When it may help

It may help when the main EBV panel is unclear.

EA-D may add information about a recent infection when it agrees with the other antibodies, illness dates, and reason for testing.

The cutoff

Each test has its own cutoff.

Use this lab's negative, unclear, or positive call. Do not compare its raw number with a result from a different test method.

Do not turn a detected antibody into a treatment plan

Detection does not tell you to take an antiviral, supplement, immune product, or restrictive diet. First ask whether it changes the clinical interpretation at all.

Save this test

Save EA-D with the panel and illness date

Keep EA-D with the other EBV antibodies, this lab's cutoff, the first illness day, immune health, the lab's full reading, and the follow-up plan.

My Fog stores the results, dates, and questions you enter so you can bring them to an appointment.

02

How age, pregnancy, and immune health affect this test

There are no separate healthy EA-D targets for age, sex, or pregnancy. Age changes how common past EBV is. Pregnancy, immune health, illness severity, and transplant care change how the result is used.

Children and teenagers

Monospot can miss EBV in young children, and their illness may be mild or unusual. Teens are more likely to have classic mono. Read EA-D with symptoms and the core EBV panel.

Pregnancy and breastfeeding

The blood draw needs no special steps during pregnancy. Tell the clinician about fever, dehydration, liver problems, severe illness, and medicines. A mother's positive IgG result describes her antibodies, not the baby's health.

Men and women

There is no separate EA-D cutoff for men and women. Use the lab's call and the full panel. Symptoms, immune health, medicines, and illness dates matter more than sex.

Older adults

Most older adults have had EBV, and EA-D can stay positive without current illness. New fatigue, memory trouble, weight loss, fever, swollen nodes, or anemia need their own checks. So do medicine side effects, sleep problems, thyroid disease, or brain and nerve changes.

Immune suppression and transplant

A weak immune system can make antibodies late, weak, or hard to read. Transplant teams may use a set EBV DNA sample and action plan. EA-D can't replace that plan.

03

Before an EBV EA-D IgG blood test

Ask why EA-D was added. It may help when a mono-like illness and the three core antibodies do not settle the timing. It is not a general test for fatigue or brain fog.

Ask for the full panel and the lab's full reading. Save VCA IgM, VCA IgG, EBNA IgG, EA-D IgG, each lab call, the unit and cutoff, and any advice to repeat an unclear result.

Note the first day you had fever, sore throat, swollen glands, rash, strong fatigue, or belly pain. EA-D may fall after the first illness but can also stay for years.

Tell the clinician about HIV, a transplant, cancer care, medicines that weaken the immune system, an immune disorder, recent blood products, or immunoglobulin treatment. EBV DNA may answer some specialist questions better.

Prepare as you would for a routine blood draw. Fast only if another ordered test requires it.

If mono is possible, ask about an exam, blood counts, liver tests, fluids, and exercise limits. EA-D IgG cannot check breathing, liver injury, low blood counts, dehydration, or an enlarged spleen.

01

Start with why the test was ordered

Ask why EA-D was added: a recent mono-like illness, an unclear core panel, or an immune-risk question. Start with that reason, not the size of the number.

02

Read all four antibodies together

Put EA-D beside VCA IgM, VCA IgG, and EBNA IgG. Add each lab call and the illness dates. One detected antibody cannot tell the timing.

03

Use this lab's cutoff

Save the lab, test method, unit, and cutoff. ARUP calls 8.9 U/mL or less not detected, 9.0 to 10.9 unclear, and 11.0 or more detected. These numbers apply only to ARUP's test.

04

Ask what changes next

Repeat antibodies, a different method, CBC, liver tests, other infection tests, or EBV DNA only when the answer will change care.

04

How to read an EA-D IgG result

Start with the lab's negative, unclear, or positive call. Then read it beside VCA IgM, VCA IgG, EBNA IgG, the first day of illness, immune health, and the reason for testing. Do not compare raw U/mL numbers from different methods.

Not detected by the performing laboratory

The test found no EA-D antibody. Use VCA IgM, VCA IgG, EBNA, illness dates, and the test method to work out whether an infection is recent or old.

Indeterminate or equivocal

Indeterminate or equivocal by the performing laboratory

The result is unclear. Check the full panel, illness dates, immune health, method, and lab advice. ARUP says a repeat in 10 to 14 days may help when the answer will change care.

Detected by the performing laboratory

EA-D antibody was found. It may come from a recent infection, some cases of active virus, or an old result that stayed positive. The rest of the panel and illness dates show which answer fits best.

A positive result may stay for years

CDC says about 1 in 5 healthy people may keep EA antibodies for years. A positive or high result doesn't prove that EBV is active now or causing fatigue or brain fog.

See research details

The research details explain how long EA-D may last, how test methods differ, what a Long COVID study found, and why some people need EBV DNA testing.

SourceCDC gives the persistence warning ContextEA IgG appears during the acute phase and generally falls to undetectable levels after three to six months, but persistent positivity occurs in roughly one healthy person in five.

Use EA-D as supporting context inside the full panel. Do not translate detected into active symptomatic EBV without the rest of the clinical evidence.

SourceARUP's numbers belong to its assay ContextARUP reports 8.9 U/mL or less as not detected, 9.0 to 10.9 as indeterminate, and 11.0 or greater as detected. It notes that results from different manufacturers are not interchangeable.

Use the cutoff printed on the person's report. For ARUP's indeterminate result, repeating in 10 to 14 days may help if the timing question still matters.

SourceEA-D adds little to routine staging for many people ContextCrowley and colleagues found EA IgG in 72 percent of 25 confirmed mono cases and large performance differences between ELISA and CLIA in a 68-sample comparison.

The authors concluded that EA IgG did not play a significant role in differentiating EBV infection stages in immunocompetent people. The standard panel remains the starting point.

SourceLong COVID research shows association, not proof ContextThe Peluso study followed 280 adults after COVID-19 and assessed symptoms at a median of four months. EA-D positivity or high EBNA IgG was associated with fatigue or neurocognitive symptoms, but not with ongoing EBV viremia.

This does not make EA-D a Long COVID diagnosis, prove the direction of cause, or show that treating EBV will improve one person's symptoms.

SourceImmune suppression uses a different pathway ContextCurrent ARUP guidance says molecular testing is often preferred when the question is EBV reactivation, particularly in immune-suppressed or transplant care where viral-load trends can guide a defined protocol.

Do not substitute an EA-D result for a transplant team's EBV DNA method, sample type, monitoring schedule, or action threshold.

05

Care for the illness you have now

Care for the illness you have now and notice what changes. Do not try to treat the EA-D number. If symptoms last, keep checking other causes.

If mono is current, support recovery

Drink enough fluid, rest when needed, and follow the plan for pain or fever. Avoid contact sports until a clinician says your recovery and spleen risk make it safe.

Keep a dated symptom course

Record fever, throat pain, swollen glands, rash, belly pain, sleep, fluids, activity, and whether fatigue or thinking is getting better. Add the blood-draw date and first illness day.

Check other causes of lasting symptoms

Ask about sleep, medicines, anemia, iron, B12, thyroid, glucose, liver health, autonomic symptoms, mood, another infection, and new brain or nerve signs.

Do not treat the antibody

A positive EA-D is no reason to start antivirals, lysine, herbs, immune boosters, binders, fasting, a strict diet, or high-dose supplements. First ask what illness needs treatment.

When to get urgent help

Get urgent help for severe or sudden upper-left abdominal pain, fainting, trouble breathing or swallowing, marked dehydration, confusion, seizure, jaundice, unusual bleeding, or rapidly worsening illness. Do not wait for another antibody panel.

06

What to save before the next appointment

Keep these together

  • EA-D lab call and number, unit, cutoff, lab, test method, and blood-draw date.
  • VCA IgM, VCA IgG, EBNA IgG, the lab's full reading, and any advice to repeat the test.
  • First illness day, fever, sore throat, swollen glands, rash, abdominal pain, fatigue, thinking changes, and recovery course.
  • Immune-suppressing medicines, transplant or cancer treatment, immune deficiency, recent blood products, and immunoglobulin treatment.
  • CBC, liver tests, examination findings, other infection tests, specialist plan, and the decision this result changed.

Question for the visit

“Ask whether EA-D changes how the full panel is read, whether an unclear result should be checked again, and what decision a repeat test or EBV DNA test would change.”
07

Sources for EBV Early Antigen D IgG (EA-D IgG)

See each claim's sources

limitation

CDC says EA IgG generally becomes undetectable after three to six months but may persist for years in some healthy people, so detection does not establish active symptomatic infection.

procedure

ARUP's current assay reports 8.9 U/mL or less as not detected, 9.0 to 10.9 as indeterminate, and 11.0 or greater as detected, with a possible 10 to 14 day repeat for an indeterminate result.

limitation

Crowley and colleagues found method-dependent performance and concluded that EA IgG did not add significant stage-differentiation value in immunocompetent people.

context

The 2023 Peluso study found an association between EA-D positivity or high EBNA IgG and selected Long COVID symptoms in 280 adults, but not ongoing EBV viremia; it does not establish causation or a treatment target.

safety

Current ARUP guidance prefers molecular testing for defined reactivation questions and separates transplant viral-load monitoring from routine serology interpretation.